These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86 related articles for article (PubMed ID: 8304174)
1. Selective inhibition of dihydrofolate reductase from problem human pathogens. Then RL; Hartman PG; Kompis I; Santi D Adv Exp Med Biol; 1993; 338():533-6. PubMed ID: 8304174 [No Abstract] [Full Text] [Related]
2. Dihydrofolate reductase from the pathogenic fungus Pneumocystis carinii: catalytic properties and interaction with antifolates. Margosiak SA; Appleman JR; Santi DV; Blakley RL Arch Biochem Biophys; 1993 Sep; 305(2):499-508. PubMed ID: 8373187 [TBL] [Abstract][Full Text] [Related]
3. Cloning and characterization of a novel trimethoprim-resistant dihydrofolate reductase from a nosocomial isolate of Staphylococcus aureus CM.S2 (IMCJ1454). Sekiguchi J; Tharavichitkul P; Miyoshi-Akiyama T; Chupia V; Fujino T; Araake M; Irie A; Morita K; Kuratsuji T; Kirikae T Antimicrob Agents Chemother; 2005 Sep; 49(9):3948-51. PubMed ID: 16127079 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of bacterial adhesion by sub-inhibitory concentrations: brodimoprim vs trimethoprim. Braga PC; Piatti G; Limoli A; Santoro M; Gazzola T J Chemother; 1993 Dec; 5(6):447-52. PubMed ID: 8195836 [TBL] [Abstract][Full Text] [Related]
5. Quantitative structure-activity relationships of the inhibition of Pneumocystis carinii dihydrofolate reductase by 4,6-diamino-1,2-dihydro-2,2-dimethyl-1-(X-phenyl)-s-triazines. Marlowe CK; Selassie CD; Santi DV J Med Chem; 1995 Mar; 38(6):967-72. PubMed ID: 7699713 [TBL] [Abstract][Full Text] [Related]
6. 2,4-Diamino-6,7-dihydro-5H-cyclopenta[d]pyrimidine analogues of trimethoprim as inhibitors of Pneumocystis carinii and Toxoplasma gondii dihydrofolate reductase. Rosowsky A; Papoulis AT; Queener SF J Med Chem; 1998 Mar; 41(6):913-8. PubMed ID: 9526565 [TBL] [Abstract][Full Text] [Related]
7. The amino-acid sequence of the dihydrofolate reductase of a trimethoprim-resistant strain of Escherichia coli. Stone D; Phillips AW; Burchall JJ Eur J Biochem; 1977 Feb; 72(3):613-24. PubMed ID: 320005 [TBL] [Abstract][Full Text] [Related]
8. Pyrrolo[2,3-d]pyrimidines and pyrido[2,3-d]pyrimidines as conformationally restricted analogues of the antibacterial agent trimethoprim. Kuyper LF; Garvey JM; Baccanari DP; Champness JN; Stammers DK; Beddell CR Bioorg Med Chem; 1996 Apr; 4(4):593-602. PubMed ID: 8735847 [TBL] [Abstract][Full Text] [Related]
9. Conformationally restricted analogues of trimethoprim: 2,6-diamino-8-substituted purines as potential dihydrofolate reductase inhibitors from Pneumocystis carinii and Toxoplasma gondii. Gangjee A; Vasudevan A; Queener SF J Med Chem; 1997 Sep; 40(19):3032-9. PubMed ID: 9301665 [TBL] [Abstract][Full Text] [Related]
10. The purification and properties of the trimethoprim-resistant dihydrofolate reductase mediated by the R-factor, R388. Amyes SG; Smith JT Eur J Biochem; 1976 Jan; 61(2):597-603. PubMed ID: 2472 [TBL] [Abstract][Full Text] [Related]
11. Plasmid-mediated trimethoprim-resistance in Staphylococcus aureus. Characterization of the first gram-positive plasmid dihydrofolate reductase (type S1). Young HK; Skurray RA; Amyes SG Biochem J; 1987 Apr; 243(1):309-12. PubMed ID: 3606580 [TBL] [Abstract][Full Text] [Related]
12. Tetroxoprim--a new inhibitor of bacterial dihydrofolate reductase. Aschhoff HS; Vergin H J Antimicrob Chemother; 1979 Nov; 5(B):19-25. PubMed ID: 43863 [No Abstract] [Full Text] [Related]
13. Quantitative structure-activity relationships for the inhibition of Escherichia coli dihydrofolate reductase by 5-(substituted benzyl)-2,4-diaminopyrimidines. Li RL; Poe M J Med Chem; 1988 Feb; 31(2):366-70. PubMed ID: 3276891 [TBL] [Abstract][Full Text] [Related]
14. Antibacterial synergism: a proposal for chemotherapeutic potentiation between trimethoprim and sulfamethoxazole. Poe M Science; 1976 Oct; 194(4264):533-5. PubMed ID: 788154 [TBL] [Abstract][Full Text] [Related]
15. Solution of the conformation and alignment tensors for the binding of trimethoprim and its analogs to dihydrofolate reductase: 3D-quantitative structure-activity relationship study using molecular shape analysis, 3-way partial least-squares regression, and 3-way factor analysis. Dunn WJ; Hopfinger AJ; Catana C; Duraiswami C J Med Chem; 1996 Nov; 39(24):4825-32. PubMed ID: 8941396 [TBL] [Abstract][Full Text] [Related]
16. [Mechanism of bactericidal action of folic acid antagonists]. Then R Zentralbl Bakteriol Orig A; 1974; 228(1):273-7. PubMed ID: 4154679 [No Abstract] [Full Text] [Related]
17. Inhibition of Pneumocystis dihydrofolate reductase by analogs of pyrimethamine, methotrexate and trimetrexate. Queener SF J Protozool; 1991; 38(6):154S-157S. PubMed ID: 1840146 [TBL] [Abstract][Full Text] [Related]
18. Activity of antifolates against Pneumocystis carinii dihydrofolate reductase and identification of a potent new agent. Allegra CJ; Kovacs JA; Drake JC; Swan JC; Chabner BA; Masur H J Exp Med; 1987 Mar; 165(3):926-31. PubMed ID: 2950200 [TBL] [Abstract][Full Text] [Related]
19. Crystal Structures of Trimethoprim-Resistant DfrA1 Rationalize Potent Inhibition by Propargyl-Linked Antifolates. Lombardo MN; G-Dayanandan N; Wright DL; Anderson AC ACS Infect Dis; 2016 Feb; 2(2):149-56. PubMed ID: 27624966 [TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, antibacterial activity and docking study of some new trimethoprim derivatives. Rashid U; Ahmad W; Hassan SF; Qureshi NA; Niaz B; Muhammad B; Imdad S; Sajid M Bioorg Med Chem Lett; 2016 Dec; 26(23):5749-5753. PubMed ID: 28327306 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]